Related Experiment Video
Updated: Jun 10, 2026
17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Studies on variability of the micromass teratogen test
Summary
The micromass assay, an in vitro test for predicting teratogenic potential, shows improved reproducibility when key procedural variations are controlled. This enhances its reliability for pharmaceutical and chemical safety testing.
Area of Science:
- Toxicology and Pharmacology
- In Vitro Assays
- Reproductive Toxicology
Background:
- The micromass assay is a crucial in vitro method for evaluating the teratogenic potential of chemical and pharmaceutical compounds.
- Reproducibility challenges in the micromass assay may impact its reliability in interlaboratory validation studies.
Purpose of the Study:
- To identify and analyze sources of variability within the micromass assay system.
- To provide recommendations for improving the reproducibility of the micromass assay results.
Main Methods:
- Investigated potential variations in micromass preparation, including tissue source and preparation time.
- Assessed subjectivity in endpoint measurement and variations in experimental design.
- Analyzed the impact of these factors on test result reproducibility.
Main Results:
- Variability in micromass preparation (tissue source, time) can influence reproducibility.
- Subjectivity in endpoint measurement introduces variability.
- Differences in experimental design can affect test outcome consistency.
Conclusions:
- Controlling identified sources of variability is essential for enhancing micromass assay reproducibility.
- Standardization of techniques is recommended for reliable teratogenicity prediction.
- Improved reproducibility supports the ongoing validation of the micromass assay for regulatory use.
More Related Videos
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
12:56An Automated Method to Perform The In Vitro Micronucleus Assay using Multispectral Imaging Flow Cytometry
Published on: May 13, 2019
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.